Last reviewed · How we verify
NCT04661293: AMDC
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)
trial testing Autologous Muscle Derived Cells (AMDCs). Temporarily not available.
Quick facts
| Lead sponsor | Cook MyoSite |
|---|---|
| Status | TEMPORARILY NOT AVAILABLE |
| Study type | EXPANDED_ACCESS |
| Sites | 1 location across United States |
Drugs / interventions tested
- Autologous Muscle Derived Cells (AMDCs) — full drug profile →
Sponsor
Cook MyoSite — full company profile →
Who can join
Eligibility, any sex. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an expanded access program (EAP) for eligible participants designed to provide access to autologous muscle derived cells (AMDCs). Treating physicians may submit requests for expanded access to Cook MyoSite's investigational product by email to MYO-ExpandedAccess@CookMyoSite.com.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04661293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cook MyoSite trials
Trials by the same sponsor.
- NCT02291432 — Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery · Phase 1, PHASE2 · completed
- NCT01893138 — Autologous Muscle Derived Cells for Female Urinary Sphincter Repair · Phase 3 · completed
- NCT01600755 — Autologous Cell Therapy for Treatment of Fecal Incontinence · Phase 1, PHASE2 · completed
- NCT01382602 — Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study · Phase 3 · completed
- NCT01008943 — Autologous Cell Therapy for Female Stress Urinary Incontinence · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04661293 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cook MyoSite
- Last refreshed: 13 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04661293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing